Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,153 | -274,448 | -133,725 | -94,879 | -52,195 |
| Depreciation Amortization | 1,446 | 6,580 | 5,243 | 3,686 | 1,716 |
| Accounts payable and accrued liabilities | 2,383 | -2,339 | -2,664 | -1,885 | -1,654 |
| Other Working Capital | -1,084 | -9,894 | -10,566 | -10,430 | -9,554 |
| Other Operating Activity | -17,102 | 130,077 | 23,939 | 14,312 | 6,949 |
| Operating Cash Flow | $-38,510 | $-150,024 | $-117,773 | $-89,196 | $-54,738 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,467 | 95,785 | 85,675 | 82,527 | 69,712 |
| PPE Investments | -89 | -41,688 | -213 | -414 | -246 |
| Investing Cash Flow | $17,378 | $54,097 | $85,462 | $82,113 | $69,466 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | 50,000 | 50,000 | N/A | N/A |
| Common Stock Issued | 1,722 | 407 | 184 | 184 | 0 |
| Other Financing Activity | 0 | -1 | 0 | 0 | 1 |
| Financing Cash Flow | $51,722 | $50,406 | $50,184 | $184 | $1 |
| Beginning Cash Position | 61,766 | 107,287 | 107,287 | 107,287 | 107,287 |
| End Cash Position | 92,356 | 61,766 | 125,160 | 100,388 | 122,016 |
| Net Cash Flow | $30,590 | $-45,521 | $17,873 | $-6,899 | $14,729 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,510 | -150,024 | -117,773 | -89,196 | -54,738 |
| Capital Expenditure | -89 | -41,975 | -476 | -414 | -246 |
| Free Cash Flow | -38,599 | -191,999 | -118,249 | -89,610 | -54,984 |